Blood and Blood Components Market By Product (Whole Blood, Blood Components, Blood Derivatives) , By Application (Anemia, Trauma & Surgery, Cancer Treatment, Bleeding Disorders) By End User (Hospitals, Ambulatory Surgical Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

September 2024 | 300 pages | ID: B53A39BEEA2EEN
Allied Market Research

Abstracts

Blood and Blood Components Market Expected to Garner $18.6 Billion by 2033, Growing at a CAGR of 3.8%

Abstract: The global blood and blood components market is expected to grow primarily due to the rising global incidence of chronic diseases and advancements in blood processing & testing technologies. The North America region is predicted to witness profitable growth by 2033.

As per the report published by Research Dive, the global blood and blood components market was valued at $12.9 billion in 2023 and is expected to register a revenue of $18.6 billion by 2033 at a CAGR of 3.8% during the forecast period 2024-2033.

Dynamics of the Market

The increasing prevalence of accidents and surgical procedures, growing incidence of chronic diseases, and the rising demand for blood transfusions are expected to make the blood and blood components market a highly profitable one in the forecast period. Besides, the use of blood and blood components is expanding across various medical procedures, including organ transplants, cancer treatments, and aesthetic procedures, thereby driving market growth.

However, according to market analysts, the high compliance cost, stringent regulations, and diverse regulatory frameworks across different regions might restrain the growth of the market.

Advancements in blood processing, storage, and testing technologies enhance the efficiency and safety of blood products, which is predicted to offer numerous growth opportunities for the market in the forecast period. Moreover, ongoing R&D efforts aimed at improving blood technologies present significant opportunities for blood and blood components market growth, enabling healthcare providers to meet increasing demand confidently.

Key Players of the Market

The major players of the blood and blood components market include Becton, Dickinson & Co., Bio-Rad Laboratories, Inc., Kidde-Fenwal Inc., Cerus Corporation, Beckman Coulter, Inc., Immucor, bioMйrieux SA, Abbott, and Octapharma AG.

What the Report Covers

In addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter’s five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Analysis of raw material in a product (by %)
• Investment Opportunities
• Technology Trend Analysis
• Consumer Preference and Product Specifications
• Market share analysis of players by products/segments
• New Product Development/ Product Matrix of Key Players
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Criss-cross segment analysis- market size and forecast
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)
• Market share analysis of players at global/region/country level
• SWOT Analysis

Key Market Segments

By Product

• Whole Blood
• Blood Components
• Blood Derivatives

By Application

• Anemia
• Trauma Surgery
• Cancer Treatment
• Bleeding Disorders

By End User

• Hospitals
• Ambulatory Surgical Centers
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• France
• Germany
• Italy
• Spain
• UK
• Russia
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Malaysia
• Indonesia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• South Africa
• Saudi Arabia
• UAE
• Argentina
• Rest of LAMEA
• Key Market Players
• Becton
• Dickinson & Co.
• Kidde-Fenwal Inc.
• Bio-Rad Laboratories, Inc.
• Cerus Corporation
• Immucor
• Beckman Coulter, Inc.
• BioMerieux SA
• Octapharma AG
• Abbott

Contents

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
  1.4.1. Primary Research
  1.4.2. Secondary Research
  1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
  3.2.1. Top Investment Pockets
  3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
  3.3.1. Bargaining Power of Suppliers
  3.3.2. Threat of New Entrants
  3.3.3. Threat of Substitutes
  3.3.4. Competitive Rivalry
  3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
  3.4.1. Drivers
  3.4.2. Restraints
  3.4.3. Opportunities

CHAPTER 4: BLOOD AND BLOOD COMPONENTS MARKET, BY PRODUCT

4.1. Market Overview
  4.1.1 Market Size and Forecast, By Product
4.2. Whole Blood
  4.2.1. Key Market Trends, Growth Factors and Opportunities
  4.2.2. Market Size and Forecast, By Region
  4.2.3. Market Share Analysis, By Country
4.3. Blood Components
  4.3.1. Key Market Trends, Growth Factors and Opportunities
  4.3.2. Market Size and Forecast, By Region
  4.3.3. Market Share Analysis, By Country
4.4. Blood Derivatives
  4.4.1. Key Market Trends, Growth Factors and Opportunities
  4.4.2. Market Size and Forecast, By Region
  4.4.3. Market Share Analysis, By Country

CHAPTER 5: BLOOD AND BLOOD COMPONENTS MARKET, BY APPLICATION

5.1. Market Overview
  5.1.1 Market Size and Forecast, By Application
5.2. Anemia
  5.2.1. Key Market Trends, Growth Factors and Opportunities
  5.2.2. Market Size and Forecast, By Region
  5.2.3. Market Share Analysis, By Country
5.3. Trauma Surgery
  5.3.1. Key Market Trends, Growth Factors and Opportunities
  5.3.2. Market Size and Forecast, By Region
  5.3.3. Market Share Analysis, By Country
5.4. Cancer Treatment
  5.4.1. Key Market Trends, Growth Factors and Opportunities
  5.4.2. Market Size and Forecast, By Region
  5.4.3. Market Share Analysis, By Country
5.5. Bleeding Disorders
  5.5.1. Key Market Trends, Growth Factors and Opportunities
  5.5.2. Market Size and Forecast, By Region
  5.5.3. Market Share Analysis, By Country

CHAPTER 6: BLOOD AND BLOOD COMPONENTS MARKET, BY END USER

6.1. Market Overview
  6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
  6.2.1. Key Market Trends, Growth Factors and Opportunities
  6.2.2. Market Size and Forecast, By Region
  6.2.3. Market Share Analysis, By Country
6.3. Ambulatory Surgical Centers
  6.3.1. Key Market Trends, Growth Factors and Opportunities
  6.3.2. Market Size and Forecast, By Region
  6.3.3. Market Share Analysis, By Country
6.4. Others
  6.4.1. Key Market Trends, Growth Factors and Opportunities
  6.4.2. Market Size and Forecast, By Region
  6.4.3. Market Share Analysis, By Country

CHAPTER 7: BLOOD AND BLOOD COMPONENTS MARKET, BY REGION

7.1. Market Overview
  7.1.1 Market Size and Forecast, By Region
7.2. North America
  7.2.1. Key Market Trends and Opportunities
  7.2.2. Market Size and Forecast, By Product
  7.2.3. Market Size and Forecast, By Application
  7.2.4. Market Size and Forecast, By End User
  7.2.5. Market Size and Forecast, By Country
  7.2.6. U.S. Blood and Blood Components Market
    7.2.6.1. Market Size and Forecast, By Product
    7.2.6.2. Market Size and Forecast, By Application
    7.2.6.3. Market Size and Forecast, By End User
  7.2.7. Canada Blood and Blood Components Market
    7.2.7.1. Market Size and Forecast, By Product
    7.2.7.2. Market Size and Forecast, By Application
    7.2.7.3. Market Size and Forecast, By End User
  7.2.8. Mexico Blood and Blood Components Market
    7.2.8.1. Market Size and Forecast, By Product
    7.2.8.2. Market Size and Forecast, By Application
    7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
  7.3.1. Key Market Trends and Opportunities
  7.3.2. Market Size and Forecast, By Product
  7.3.3. Market Size and Forecast, By Application
  7.3.4. Market Size and Forecast, By End User
  7.3.5. Market Size and Forecast, By Country
  7.3.6. France Blood and Blood Components Market
    7.3.6.1. Market Size and Forecast, By Product
    7.3.6.2. Market Size and Forecast, By Application
    7.3.6.3. Market Size and Forecast, By End User
  7.3.7. Germany Blood and Blood Components Market
    7.3.7.1. Market Size and Forecast, By Product
    7.3.7.2. Market Size and Forecast, By Application
    7.3.7.3. Market Size and Forecast, By End User
  7.3.8. Italy Blood and Blood Components Market
    7.3.8.1. Market Size and Forecast, By Product
    7.3.8.2. Market Size and Forecast, By Application
    7.3.8.3. Market Size and Forecast, By End User
  7.3.9. Spain Blood and Blood Components Market
    7.3.9.1. Market Size and Forecast, By Product
    7.3.9.2. Market Size and Forecast, By Application
    7.3.9.3. Market Size and Forecast, By End User
  7.3.10. UK Blood and Blood Components Market
    7.3.10.1. Market Size and Forecast, By Product
    7.3.10.2. Market Size and Forecast, By Application
    7.3.10.3. Market Size and Forecast, By End User
  7.3.11. Russia Blood and Blood Components Market
    7.3.11.1. Market Size and Forecast, By Product
    7.3.11.2. Market Size and Forecast, By Application
    7.3.11.3. Market Size and Forecast, By End User
  7.3.12. Rest Of Europe Blood and Blood Components Market
    7.3.12.1. Market Size and Forecast, By Product
    7.3.12.2. Market Size and Forecast, By Application
    7.3.12.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
  7.4.1. Key Market Trends and Opportunities
  7.4.2. Market Size and Forecast, By Product
  7.4.3. Market Size and Forecast, By Application
  7.4.4. Market Size and Forecast, By End User
  7.4.5. Market Size and Forecast, By Country
  7.4.6. China Blood and Blood Components Market
    7.4.6.1. Market Size and Forecast, By Product
    7.4.6.2. Market Size and Forecast, By Application
    7.4.6.3. Market Size and Forecast, By End User
  7.4.7. Japan Blood and Blood Components Market
    7.4.7.1. Market Size and Forecast, By Product
    7.4.7.2. Market Size and Forecast, By Application
    7.4.7.3. Market Size and Forecast, By End User
  7.4.8. India Blood and Blood Components Market
    7.4.8.1. Market Size and Forecast, By Product
    7.4.8.2. Market Size and Forecast, By Application
    7.4.8.3. Market Size and Forecast, By End User
  7.4.9. South Korea Blood and Blood Components Market
    7.4.9.1. Market Size and Forecast, By Product
    7.4.9.2. Market Size and Forecast, By Application
    7.4.9.3. Market Size and Forecast, By End User
  7.4.10. Australia Blood and Blood Components Market
    7.4.10.1. Market Size and Forecast, By Product
    7.4.10.2. Market Size and Forecast, By Application
    7.4.10.3. Market Size and Forecast, By End User
  7.4.11. Thailand Blood and Blood Components Market
    7.4.11.1. Market Size and Forecast, By Product
    7.4.11.2. Market Size and Forecast, By Application
    7.4.11.3. Market Size and Forecast, By End User
  7.4.12. Malaysia Blood and Blood Components Market
    7.4.12.1. Market Size and Forecast, By Product
    7.4.12.2. Market Size and Forecast, By Application
    7.4.12.3. Market Size and Forecast, By End User
  7.4.13. Indonesia Blood and Blood Components Market
    7.4.13.1. Market Size and Forecast, By Product
    7.4.13.2. Market Size and Forecast, By Application
    7.4.13.3. Market Size and Forecast, By End User
  7.4.14. Rest of Asia-Pacific Blood and Blood Components Market
    7.4.14.1. Market Size and Forecast, By Product
    7.4.14.2. Market Size and Forecast, By Application
    7.4.14.3. Market Size and Forecast, By End User
7.5. LAMEA
  7.5.1. Key Market Trends and Opportunities
  7.5.2. Market Size and Forecast, By Product
  7.5.3. Market Size and Forecast, By Application
  7.5.4. Market Size and Forecast, By End User
  7.5.5. Market Size and Forecast, By Country
  7.5.6. Brazil Blood and Blood Components Market
    7.5.6.1. Market Size and Forecast, By Product
    7.5.6.2. Market Size and Forecast, By Application
    7.5.6.3. Market Size and Forecast, By End User
  7.5.7. South Africa Blood and Blood Components Market
    7.5.7.1. Market Size and Forecast, By Product
    7.5.7.2. Market Size and Forecast, By Application
    7.5.7.3. Market Size and Forecast, By End User
  7.5.8. Saudi Arabia Blood and Blood Components Market
    7.5.8.1. Market Size and Forecast, By Product
    7.5.8.2. Market Size and Forecast, By Application
    7.5.8.3. Market Size and Forecast, By End User
  7.5.9. UAE Blood and Blood Components Market
    7.5.9.1. Market Size and Forecast, By Product
    7.5.9.2. Market Size and Forecast, By Application
    7.5.9.3. Market Size and Forecast, By End User
  7.5.10. Argentina Blood and Blood Components Market
    7.5.10.1. Market Size and Forecast, By Product
    7.5.10.2. Market Size and Forecast, By Application
    7.5.10.3. Market Size and Forecast, By End User
  7.5.11. Rest of LAMEA Blood and Blood Components Market
    7.5.11.1. Market Size and Forecast, By Product
    7.5.11.2. Market Size and Forecast, By Application
    7.5.11.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

9.1. Becton
  9.1.1. Company Overview
  9.1.2. Key Executives
  9.1.3. Company Snapshot
  9.1.4. Operating Business Segments
  9.1.5. Product Portfolio
  9.1.6. Business Performance
  9.1.7. Key Strategic Moves and Developments
9.2. Dickinson And Co.
  9.2.1. Company Overview
  9.2.2. Key Executives
  9.2.3. Company Snapshot
  9.2.4. Operating Business Segments
  9.2.5. Product Portfolio
  9.2.6. Business Performance
  9.2.7. Key Strategic Moves and Developments
9.3. Kidde-Fenwal Inc.
  9.3.1. Company Overview
  9.3.2. Key Executives
  9.3.3. Company Snapshot
  9.3.4. Operating Business Segments
  9.3.5. Product Portfolio
  9.3.6. Business Performance
  9.3.7. Key Strategic Moves and Developments
9.4. Bio-Rad Laboratories, Inc.
  9.4.1. Company Overview
  9.4.2. Key Executives
  9.4.3. Company Snapshot
  9.4.4. Operating Business Segments
  9.4.5. Product Portfolio
  9.4.6. Business Performance
  9.4.7. Key Strategic Moves and Developments
9.5. Cerus Corporation
  9.5.1. Company Overview
  9.5.2. Key Executives
  9.5.3. Company Snapshot
  9.5.4. Operating Business Segments
  9.5.5. Product Portfolio
  9.5.6. Business Performance
  9.5.7. Key Strategic Moves and Developments
9.6. Immucor
  9.6.1. Company Overview
  9.6.2. Key Executives
  9.6.3. Company Snapshot
  9.6.4. Operating Business Segments
  9.6.5. Product Portfolio
  9.6.6. Business Performance
  9.6.7. Key Strategic Moves and Developments
9.7. Beckman Coulter, Inc.
  9.7.1. Company Overview
  9.7.2. Key Executives
  9.7.3. Company Snapshot
  9.7.4. Operating Business Segments
  9.7.5. Product Portfolio
  9.7.6. Business Performance
  9.7.7. Key Strategic Moves and Developments
9.8. BioMerieux SA
  9.8.1. Company Overview
  9.8.2. Key Executives
  9.8.3. Company Snapshot
  9.8.4. Operating Business Segments
  9.8.5. Product Portfolio
  9.8.6. Business Performance
  9.8.7. Key Strategic Moves and Developments
9.9. Octapharma AG
  9.9.1. Company Overview
  9.9.2. Key Executives
  9.9.3. Company Snapshot
  9.9.4. Operating Business Segments
  9.9.5. Product Portfolio
  9.9.6. Business Performance
  9.9.7. Key Strategic Moves and Developments
9.10. Abbott
  9.10.1. Company Overview
  9.10.2. Key Executives
  9.10.3. Company Snapshot
  9.10.4. Operating Business Segments
  9.10.5. Product Portfolio
  9.10.6. Business Performance
  9.10.7. Key Strategic Moves and Developments